InvestSMART

Audeara Limited (ASX: AUA) - Announcements

- Current share price for AUA : $0.031

ASX company news and announcements for Audeara Limited (AUA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Audeara Limited (AUA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Audeara Limited (AUA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Audeara Limited (AUA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 4G 31 Aug 2026 9:33AM $0.032 $0.031 fallen by 3.13%
$6 Appendix 4E and Annual Report 2026 31 Aug 2026 9:33AM $0.032 $0.031 fallen by 3.13%
$6 Corporate Governance Statement 31 Aug 2026 9:33AM $0.032 $0.031 fallen by 3.13%
$6 Notification regarding unquoted securities - AUA 28 Aug 2026 3:24PM $0.034 $0.031 fallen by 8.82%
$6 Cleansing Notice 28 Aug 2026 3:08PM $0.034 $0.031 fallen by 8.82%
$6 Application for quotation of securities - AUA 28 Aug 2026 3:01PM $0.034 $0.031 fallen by 8.82%
$6 Proposed issue of securities - AUA 21 Aug 2026 9:39AM $0.033 $0.031 fallen by 6.06%
$6 Proposed issue of securities - AUA 21 Aug 2026 9:39AM $0.033 $0.031 fallen by 6.06%
$6 Firm commitments of $1.26m received via Placement 21 Aug 2026 9:39AM $0.033 $0.031 fallen by 6.06%
$6 Trading Halt 19 Aug 2026 9:02AM $0.033 $0.031 fallen by 6.06%
$6 Chip-level AI Licensing Partnership Commercial Production 4 Aug 2026 8:24AM $0.031 $0.031 fallen by 0%
$6 Investor Update June 2026 30 Jul 2026 8:45AM $0.030 $0.031 risen by 3.33%
$6 Q4 FY26 Quarterly Activities Report & Appendix 4C 30 Jul 2026 8:33AM $0.030 $0.031 risen by 3.33%
$6 Change of Director's Interest Notice - David Trimboli 28 May 2026 3:32PM $0.042 $0.031 fallen by 26.19%
$6 Change of Director's Interest Notice - David Trimboli 15 May 2026 5:31PM $0.031 $0.031 fallen by 0%
$6 Transition of Chief Technology Officer 23 Apr 2026 7:03PM $0.057 $0.031 fallen by 45.61%
$6 Audeara Secures Exclusive Deal with Shokz Health Global 16 Apr 2026 8:22AM $0.057 $0.031 fallen by 45.61%
$6 Application for quotation of securities - AUA 14 Apr 2026 11:09AM $0.057 $0.031 fallen by 45.61%
$6 Q3 FY26 Quarterly Activities Report & Appendix 4C 14 Apr 2026 8:18AM $0.056 $0.031 fallen by 44.64%
$6 Auracast platform expansion underway with Clinico Inc 9 Mar 2026 9:15AM $0.074 $0.031 fallen by 58.11%
$6 Appendix 4D & Half-Year Financial Report to 31 December 2025 25 Feb 2026 2:26PM $0.070 $0.031 fallen by 55.71%
$6 Q2 FY26 Quarterly Activities Report & Appendix 4C 21 Jan 2026 8:26AM $0.061 $0.031 fallen by 49.18%
$6 Clarification to chip-level AI Licensing deal with Optek 18 Dec 2025 9:21AM $0.067 $0.031 fallen by 53.73%
$6 Audeara secures chip-level AI Licensing deal with Optek 16 Dec 2025 9:08AM $0.040 $0.031 fallen by 22.50%
$6 December Trading Update 8 Dec 2025 8:30AM $0.034 $0.031 fallen by 8.82%

1 - 25 of 285 results

Page 1 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.